IMXI
International Money Express, Inc.
IMXI trails on the overall score without a compensating advantage in the available component scores.
SNDK
Sandisk Corporation
SNDK has the edge over IMXI overall, supported by stronger fundamentals and stronger modeled upside.
IMXI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Strong |
IMXI's cash flow and balance sheet are currently healthy, and its profitability is stable, but its revenue is under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
IMXI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.4x | $6.39 | — |
| Cheap | 11x | $6.63 | +3.8% |
| Current | 11x | $6.39 | — |
| Fair | 15x | $8.92 | +40% |
| Expensive | 19x | $11.18 | +75% |
Historical ranges are pointers, not guarantees.
IMXI's PE is in its cheap range at 11x. On analysts' estimates for next year's earnings, today's price would be 7.4x.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over IMXI in the historical PE scenario, which offers more potential upside but is not a forecast.
IMXI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect IMXI's earnings and revenue to decline, with profitability weakening.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over IMXI on the outlook, with more favorable earnings and revenue expectations.
IMXI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.86 | +46% |
| Q3 2026 | $0.59 | -54% |
| Q2 2026 | $0.62 | -62% |
| Q1 2026 | $0.85 | -50% |
| Q4 2025 | $1.08 | -40% |
| Q3 2025 | $1.28 | -28% |
| Q2 2025 | $1.64 | -1.8% |
| Q1 2025 | $1.69 | +1.2% |
| Q4 2024 | $1.79 | +9.8% |
IMXI's earnings per share have fallen from their peak: $0.59 over the past year, against $1.79 in late 2024.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over IMXI in the latest year-over-year earnings comparison.
IMXI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $126.4M | -18% |
| Q2 2026 | $131.2M | -19% |
| Q1 2026 | $122M | -15% |
| Q4 2025 | $147.4M | -11% |
| Q3 2025 | $154.9M | -9.9% |
| Q2 2025 | $161.1M | -6.1% |
| Q1 2025 | $144.3M | -4.1% |
| Q4 2024 | $164.8M | -4.1% |
IMXI's revenue has slid since its 2023 peak: $126M last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +0.4 points |
| Q2 2026 | 6.7% | -5.4 points |
| Q1 2026 | 3% | -6.7 points |
| Q4 2025 | 7.8% | -7.1 points |
| Q3 2025 | 6.8% | -9.4 points |
| Q2 2025 | 12% | -1.3 points |
| Q1 2025 | 9.8% | -3.3 points |
| Q4 2024 | 15% | -1.1 points |
IMXI's operating margin was 7.2% last quarter, about level with the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over IMXI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over IMXI on profitability, with a higher operating margin.
IMXI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.3M | +$38.8M |
| Q2 2026 | $107.2M | +203% |
| Q1 2026 | -$42.9M | -219% |
| Q4 2025 | -$20M | -$11.2M |
| Q3 2025 | -$35.5M | -252% |
| Q2 2025 | $35.3M | +$61.6M |
| Q1 2025 | $36M | +3.6% |
| Q4 2024 | -$8.8M | -116% |
IMXI still generates free cash flow, though less than at its 2026 peak: $48M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over IMXI on cash flow, with more consistent year-over-year improvement.
IMXI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +49.2K shares |
| 1 year | +2.8% | +841K shares |
| 3 years | -15% | -5.4M shares |
| 5 years | -22% | -8.7M shares |
| Available history | -20% | -7.6M shares |
IMXI has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $11.4M |
| Q1 2025 | $5M |
| Q4 2024 | $20.2M |
IMXI hasn't bought back shares in the past year.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
IMXI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 0.4x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | 0.2x | Very low |
IMXI has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
IMXI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.9 | Oversold |
| Stochastic | 7.3 | Oversold |
IMXI's weekly RSI is 22 (oversold) and its Stochastic is 7 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
IMXI PE vs Technology Sector
| Metric | IMXI | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 14 | 35 | 21 pts below |
IMXI is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over IMXI on valuation relative to its sector.
IMXI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.74 | 34% below |
| 20 week MA | $12.1 | 47% below |
| 50 week MA | $14.1 | 55% below |
| 100 week MA | $14.1 | 55% below |
| 200 week MA | $17.6 | 64% below |
SNDK has stronger trend alignment. IMXI is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
IMXI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.0 | $15.9 | +32% |
| 2021 | $15.9 | $15.8 | -0.6% |
| 2022 | $15.8 | $22.5 | +43% |
| 2023 | $22.5 | $22.1 | -1.6% |
| 2024 | $22.1 | $20.6 | -6.6% |
| 2025 | $20.6 | $15.4 | -25% |
| 2026 YTD | $15.4 | $6.39 | -59% |
IMXI has finished three years in a row lower, and it's down 59% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over IMXI on returns for 2026, with the stronger performance.